Analysts are confident in iRhythm Technologies' path to profitability, expecting a high year-on-year growth rate. The company's low debt obligation reduces the risk around investing in the loss-making company.
Daniel Wilson's recent sale, even below the current price of US$113, could be seen as a discouraging sign. The lack of insider purchases over the last year and the recent sale might require careful consideration before buying shares.
The author believes iRhythm Technologies is undervalued and sees a potential future buying opportunity due to its high beta, strong foresee earnings growth and positive outlook not fully reflected in current share price.
The fact that insiders have offloaded significant shares without making any recent purchases, and despite owning a decent, but not substantial portion of the company signals caution for potential buyers of the iRhythm Technologies stock.
Latest List of Companies With Silicon Valley Bank, $SIVB, Deposits: 1. Circle: $3.3 billion 2. Bill․com: $670 million 3. Roku: $487 million 4. BlockFi: $227 million 5. Roblox: $150 million 6. Sunrun: $80 million 7. Ginkgo Bio: $74 million 8. iRhythm: $55 million 9. Rocket Lab: $38 million 10. Sangamo Thera: $34 million 11. Lending Club: $21 million 12. Huuuge Inc: $24 million 13. Payoneer: $20 million 14. Ambarella: $17 million 15. Protagonist Thera: $13 million 16. Oncorus: $10 million 17. Eig...
アイリズム テクノロジーズに関するコメント
1. Circle: $3.3 billion
2. Bill․com: $670 million
3. Roku: $487 million
4. BlockFi: $227 million
5. Roblox: $150 million
6. Sunrun: $80 million
7. Ginkgo Bio: $74 million
8. iRhythm: $55 million
9. Rocket Lab: $38 million
10. Sangamo Thera: $34 million
11. Lending Club: $21 million
12. Huuuge Inc: $24 million
13. Payoneer: $20 million
14. Ambarella: $17 million
15. Protagonist Thera: $13 million
16. Oncorus: $10 million
17. Eig...
In reaction to earnings/guidance:
$リバティ エナジー A(LBRT.US)$ +11.6%, $F5 インク(FFIV.US)$ +6.9%, $エンコア ワイヤ(WIRE.US)$ + 5.6%, $アーチャー ダニエルズ ミッドランド(ADM.US)$ +5.5%, $バンク オブ エヌティー バターフィールド&サン(NTB.US)$ +5%, $アルバニー インターナショナル A(AIN.US)$ +5%, $スリーエム(MMM.US)$ +4.0%,
Other news:
$Shell Midstream(SHLX.US)$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$ブリッジバイオ ファーマ(BBIO.US)$...
• $シグネット ジュエラーズ(SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $オックスフォード インダストリーズ(OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $ブリッジバイオ ファーマ(BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $グライフ A(GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $オレマ ファーマシューティクス(OLMA.US)$ +4.3% (an...
• $アメリカン・キャピタル・エージェンシー(AGNC.US)$ : KBW Upgrades to Outperform from Market Perform - PT $13.25 (from $12.25)
• $ダイネックス・キャピタル(DX.US)$ : KBW Upgrades to Outperform from Market Perform - PT $18.75 (from $17)
• $フリーポート マクモラン(FCX.US)$ : Credit Suisse Upgrades to Neutral from Underperform - PT $38 (from $32)
• $IAA(IAA.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $52
• $Magellan Midstream(MMP.US)$ : Goldman ...
• $バンク オブ カリフォルニア(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $カレン フロスト バンカーズ(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $WW グレインジャー(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $インビテーション・ホームズ(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB バンコープ(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
まだコメントはありません